JERUSALEM--(BUSINESS WIRE)--Feb. 24, 2012--
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live
audio webcast at the Citi 2012 Global Health Care Conference in New
York. Lesley Russell Cooper, SVP, R&D Global Branded Products, will
present on Monday, February 27, 2012.
About Teva
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
largest generic drug maker, with a global product portfolio of more than
1,300 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 47,000 people around the world and reached $18.3 billion
in net revenues in 2011.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR:
Kevin C.
Mannix, 215-591-8912 (United States)
Tomer Amitai, 972
(3) 926-7656 (Israel)
or
PR:
Denise Bradley,
215-591-8974 (United States)
Shir Altay-Hagoel, 972 (3)
926-7590 (Israel)